2-Hydroxy-5-methylpyridine - Names and IdentifiersName2-Hydroxy-5-methylpyridineSynonymsAKOS BB
Posta elettronica:services@moutainchem.com
Nome | 2-Hydroxy-5-methylpyridine |
Sinonimi | AKOS BBS-00002970 5-Methyl-2-pyridinol 6-HYDROXY-3-PICOLINE 5-METHYL-2-PYRIDINOL 5-METHYL-PYRIDIN-2-OL 2-Pyridinol,5-methyl- 5-METHYLPYRIDINE-2-ONE 5-METHYL-2(1H)PYRIDONE 5-methyl-(1H)pyridinone 5-Methyl 2-(1H)pyridinone 5-methylpyridin-2(1H)-one 5-Methyl-2(1H)pypridinone 5-METHYL-2(1H)-PYRIDINONE 5-METHYL-2(1H)PYPRIDINONE 4-methylpyridin-2(1H)-one 5-Methyl-2-(1H)pyridinone 2-Hydroxy-5-methylpyridine 5-Methyl-2-hydroxypyridine |
CAS | 1003-68-5 91914-06-6 |
EINECS | 213-713-9 |
InChI | InChI=1/C6H7NO/c1-5-2-3-7-6(8)4-5/h2-4H,1H3,(H,7,8) |
InChIKey | SOHMZGMHXUQHGE-UHFFFAOYSA-N |
Formula molecolare | C6H7NO |
massa molare | 109.13 |
Densità | 1.053±0.06 g/cm3(Predicted) |
Punto di fusione | 183-187 °C (lit.) |
punto Boling | 304.2±15.0 °C(Predicted) |
Punto Flash | 170.6 °C |
Solubilità | DMSO (Slightly), Ethanol (Slightly), Methanol (Slightly) |
Pressione del vapore | 0mmHg at 25°C |
Aspetto | White to brown powder or crystal |
Colore | Pale Yellow to Light Yellow |
BRN | 107074 |
pKa | 12.43±0.10(Predicted) |
Condizioni di conservazione | Sigillato in secco, temperatura ambiente |
Indice di rifrattività | 1.551 |
MDL | MFCD03092888 |
Proprietà fisiche e chimiche |
Simboli di pericolo | Xn - dannoso |
Codici di rischio | R22 - Nocoso se ingoiato R37/38 - Irritating to respiratory system and skin. R41 - Risk of serious damage to eyes R36/37/39 - |
Descrizione della sicurezza | S26 In caso di contatto con gli occhi, risciacquare immediatamente con abbastanza acqua e richiedere consulenza medica. S36 - Indossare abbigliamento protettivo adeguato. S37 - Wear suitable gloves. |
WGK Germania | 3 |
Codice HS | 29333990 |
Informazioni chimiche NIST | Informazioni fornite da: webbook.nist.gov (link esterno) |
Applicazione | 2-hydroxy-5-methylpyridine is a pharmaceutical intermediate that can be used to prepare pirfenidone. Pirfenidone is a new pyridone compound with broad-spectrum anti-fibrosis effect, which is a white or light yellow crystalline powder. It can prevent and reverse the formation of fibrosis and scars; and the drug also has a good effect in renal interstitial fibrosis, liver fibrosis and other fibrotic diseases; at the same time, it is also used in kidney disease (focal segmental glomerulosclerosis), Hypertrophic cardiomyopathy, adult type I multiple neurofibroma, adolescent type I multiple neurofibroma and plexiform neurofibroma, diabetes with kidney disease, uterine leiomyoma and other phase II clinical studies have a wide range of applications. |
preparation | (1) mix 2-amino -5-methylpyridine, diazotization reagent and water evenly, cool to -4 ℃-3 ℃, add acidic solution for heat preservation reaction; After the reaction is complete, heat hydrolysis and cooling, and then adjust the pH to 6.5-7.5 with a mass fraction of 30% sodium hydroxide solution, the organic phase is extracted by the first solvent, dried and concentrated under reduced pressure to obtain 2-hydroxy-5-methylpyridine crude product;(2) A second solvent is added to the 2-hydroxy-5-methylpyridine crude product, heated and refluxed, cooled and crystallizated, pumped and dried to produce 2-hydroxy-5-methylpyridine pure product. |
Disclaimer: Il contenuto di cui sopra è per riferimento e comunicazione solo tra addetti ai lavori del settore e non garantisce la sua accuratezza o completezza. Secondo le leggi e i regolamenti pertinenti e i regolamenti di questo sito web, le unità o le persone fisiche che acquistano articoli correlati devono ottenere qualifiche e condizioni di qualificazione valide.
Telefono aziendale
+86-21-6420 0566
Orario di lavoro
Da lunedì a venerdì
Telefono cellulare:
13816217984
Posta elettronica:
info@qinsun-lab.com